$Cassava Sciences (SAVA.US)$ News spreading and all of those...
$Cassava Sciences(SAVA.US$ News spreading and all of those patients enrolled will be getting treatment from simufilam in trials, a well tolerated and prone to show cognition improvement, slowing decline on mild Alzheimer’s patients.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
